LifeLens Technologies
Private Company
Funding information not available
Overview
LifeLens Technologies, founded in 2015 and based in San Francisco, has developed an FDA-cleared, multi-parameter wearable monitoring platform focused on comprehensive physiological data capture. The company's technology differentiates itself through rugged wearability designed to work under personal protective equipment, making it suitable for tactical military, first responder, and healthcare applications. Its business model appears to be a platform/device-based model, generating revenue through the sale of its monitoring systems and associated services. Key evidence of commercial traction includes a publicized partnership with the U.S. Department of Defense's Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND).
Technology Platform
A multi-parameter, wearable physiological monitoring platform that integrates physiological, contextual, and environmental sensors. It is designed for durability and reliable operation under personal protective equipment, featuring FDA-cleared ECG monitoring, real-time/retrospective data visualization, and secure connectivity.
Opportunities
Risk Factors
Competitive Landscape
LifeLens competes in the wearable monitoring space against traditional Holter monitor companies, newer patch-based ECG providers (e.g., iRhythm), and consumer tech companies moving into health. Its primary differentiation is a rugged, multi-parameter platform validated for extreme environments, which sets it apart in the tactical and industrial monitoring segments.